Medtronic Sales High Despite Challenges for Heart and Spine Implants

Medtronic reported a 3 percent rise in overall revenue in the second fiscal quarter despite ongoing challenges with its heart and spine implants, according to a Washington Post report.

Sales of the company's spinal implants and heart defibrillators, which account for about 40 percent of total sales, had been weak for more than a year and were down 5 percent this quarter as well. Overall revenue reached $4.13 billion and was boosted by sales of heart valves, stents and other upgraded products.

Related Articles on Medical Devices:
FDA Clears Aptus Endosystems EndoStapling System
Doctors Question the Value of Robot-Assisted Surgery
FDA Studying New Heart Stents that Stretch After Implantation

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers